Le Lézard
Classified in: Health
Subject: TDS

FDAnews Announces -- Early Bird Pricing Ends on May 3, EU-Medical Device Regulation and In-vitro Diagnostic Compliance Workshop June 10-12, 2019 Waltham, MA

FALLS CHURCH, Va., April 26, 2019 /PRNewswire-PRWeb/ -- EU-Medical Device Regulation and In-vitro Diagnostic Compliance Workshop
Interactive Workshop Training from FDAnews and Ombu Enterprises
June 10-12, 2019 ? Waltham, MA (Boston)

Early bird pricing for EU-Medical Device Regulation and In-vitro Diagnostic Compliance Workshop ends on May 3.

Understanding and Implementing the EU-MDR & EU-IVDR: June 10-11, 2019
Post-Market Activities in the EU-MDR ? A Detailed Analysis: June 12, 2019

The EU-MDR and IVDR compliance clocks are ticking... daily. Many devicemakers still aren't ready to meet the Dates of Application. The new regulations are very complicated sets of rules!

And that's just for openers.

The new regulations are a handful. They will change the way one does business in the European Union!

Here's how we can help...

Mark the calendar for two, or three, productive days of hands-on training with Dan O'Leary of Ombu Enterprises, one of FDAnews' most in-demand trainers. Over the course of two days (June 10-11), attendees will understand the conversion and implement the new MDR:

Special Third-Day Add-On:
Post-Market Activities in the EU-MDR ? A Detailed Analysis

Stay one more day. Participate in a workshop untangling one of the most complicated aspects of the new EU-MDR post-market activities ? one will discover:

This add-on workshop assumes a basic familiarity with the EU-MDR. Attending the previous day's workshop (June 10-11) is recommended but not required to attend this (June 12) day.

The first EU-MDR compliance deadline falls in May 2020, less than a year after this workshop. There's no time to waste and space is limited. Reserve a seat today.

Early bird pricing ends on Friday May 3.

Who Should Attend:

Webinar Details:
Building a World-Class Advertising and Promotion Review Program
**A Two-Day Interactive Workshop Presented by PhillyCooke Consulting and FDAnews**
May 7-8, 2019 Boston, MA

Early Bird Pricing Course I (Days 1&2): $1,597 (available until May 3, 2019)
Regular Pricing Course I (Days 1&2): $1,797 (after May 3, 2019)
Early Bird Pricing Course II (Day 3): $797 (available until May 3, 2019)
Regular Pricing Course II (Day 3): $897 (after May 3, 2019)
Early Bird Pricing Course I & II: $1,947 (available until May 3, 2019)
Regular Pricing Course I & II: $2,197 (available until May 3, 2019)
Significant team discounts are available.

Easy Ways to Register:
Online: https://www.fdanews.com/eumdreg
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.



These press releases may also interest you

at 19:20
Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") , a North American provider of cannabis products and services, announced executive management changes as outlined below. Kevin Wilkerson has been promoted to...

at 18:46
InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their outstanding work developing groundbreaking scientific discoveries into lifesaving therapeutics for Alzheimer's, CTE and other related Dementias. The award...

at 18:00
Our Mission Many children and adults with Attention Deficit Hyperactive Disorder (ADHD) have difficulties managing their symptoms. It can be very challenging for these individuals to succeed in school, in their careers and can have struggles with...

at 17:56
Rachel Shadley-Barlow's water broke at 14 weeks (Preterm Premature Rupture of Membranes or PPROM); doctors advised that nothing could be done to safely continue the pregnancy. Rachel and her husband Jesse decided to watch and wait, supported by an...

at 17:55
Today, addiction treatment search engine WeRecover announced the launch of the WeRecover app for both iOS and Android. WeRecover is a venture-backed technology company committed to  broadening access to care for addiction treatment. They have helped...

at 17:30
Ra Pharmaceuticals, Inc. ("Ra Pharma") today announced that it intends to offer and sell, subject to market and other conditions, $100 million of its common stock in an underwritten public offering. Ra Pharma expects to grant the underwriters a...

News published on 26 april 2019 at 00:00 and distributed by: